Greenberg NM - Search Results

1

Metastatic prostate cancer in a transgenic mouse.

Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. Gingrich JR, et al. Among authors: greenberg nm. Cancer Res. 1996 Sep 15;56(18):4096-102. Cancer Res. 1996. PMID: 8797572

2

Prostate cancer in a transgenic mouse.

Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Greenberg NM, et al. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43. doi: 10.1073/pnas.92.8.3439. Proc Natl Acad Sci U S A. 1995. PMID: 7724580 Free PMC article.

3

The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice.

Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, et al. Greenberg NM, et al. Mol Endocrinol. 1994 Feb;8(2):230-9. doi: 10.1210/mend.8.2.8170479. Mol Endocrinol. 1994. PMID: 8170479

4

A transgenic mouse prostate cancer model.

Gingrich JR, Greenberg NM. Gingrich JR, et al. Among authors: greenberg nm. Toxicol Pathol. 1996 Jul-Aug;24(4):502-4. doi: 10.1177/019262339602400414. Toxicol Pathol. 1996. PMID: 8864193 No abstract available.

5

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.

Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Foster BA, et al. Among authors: greenberg nm. Cancer Res. 1997 Aug 15;57(16):3325-30. Cancer Res. 1997. PMID: 9269988

6

Androgen-independent prostate cancer progression in the TRAMP model.

Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Gingrich JR, et al. Among authors: greenberg nm. Cancer Res. 1997 Nov 1;57(21):4687-91. Cancer Res. 1997. PMID: 9354422

7

Angiogenesis and prostate cancer: identification of a molecular progression switch.

Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM. Huss WJ, et al. Among authors: greenberg nm. Cancer Res. 2001 Mar 15;61(6):2736-43. Cancer Res. 2001. PMID: 11289156

8

SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis.

Huss WJ, Barrios RJ, Greenberg NM. Huss WJ, et al. Among authors: greenberg nm. Mol Cancer Ther. 2003 Jul;2(7):611-6. Mol Cancer Ther. 2003. PMID: 12883033

9

Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.

Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, Rosen JM, Ittmann M, Greenberg NM, Spencer DM. Freeman KW, et al. Among authors: greenberg nm. Cancer Res. 2003 Oct 1;63(19):6237-43. Cancer Res. 2003. PMID: 14559809

10

Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.

Hernandez I, Maddison LA, Wei Y, DeMayo F, Petras T, Li B, Gingrich JR, Rosen JM, Greenberg NM. Hernandez I, et al. Among authors: greenberg nm. Mol Cancer Res. 2003 Dec;1(14):1036-47. Mol Cancer Res. 2003. PMID: 14707287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters